Vaccinating against <i>Helicobacter pylori</i> in the developing world

Abstract excerpt

Helicobacter pylori infects more than half the world's population and in developing nations the incidence can be over 90%. The morbidity and mortality associated with H. pylori-associated diseases including ulcers and gastric cancer therefore, disproportionately impact the developing world. Mice have been used extensively to demonstrate the feasibility of developing a vaccine for H. pylori infection, and for...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Diagnosis and treatment of tuberculosis
• Share to Eosinophilic Esophagitis
• Share to Helicobacter pylori-related gastroenterology studies